Better systems, not guidelines, for glucose monitoringBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7479.E332 (Published 09 December 2004) Cite this as: BMJ 2004;329:E332
- Paris Roach (email@example.com), associate professor of clinical medicine1
- 1 Division of Endocrinology and Metabolism Indiana University School of Medicine 545 Barnhill Drive, Emerson Hall Room 421 Indianapolis, IN 46202
Reynolds and Strachan propose that routine home blood glucose monitoring (HBGM) not be used to monitor non-insulin treated patients with type 2 diabetes due to lack of evidence of its benefit. Their underlying concerns are that unnecessary HBGM will result in unjustified costs and that it may adversely affect patients' quality of life. They also suggest that large randomized trials be performed to provide guidance on the optimal use of HBGM in this population.
The effectiveness of any glucose monitoring program is highly dependent on the ability …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial